Curasight Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Public

  • Employees
  • 6

Employees

  • Stock Symbol
  • CURAS

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $1.10
  • (As of Friday Closing)

Curasight General Information

Description

Curasight AS is a clinical-stage radiopharmaceutical company based in Copenhagen, Denmark, developing uTREAT, a first-in-class uPAR-targeted radioligand therapy (RLT) platform designed to treat aggressive solid tumors. The Company is focused on advancing its diagnostic and therapeutic platforms through key clinical milestones.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Ole Maaløes Vej 3
  • 2200 Copenhagen
  • Denmark
+45 22
Primary Industry
Biotechnology
Other Industries
Diagnostic Equipment
Stock Exchange
SAT
Vertical(s)
Corporate Office
  • Ole Maaløes Vej 3
  • 2200 Copenhagen
  • Denmark
+45 22

Curasight Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Curasight Stock Performance

As of 20-Nov-2026, Curasight’s stock price is $1.10. Its current market cap is $54.4M with 49.5M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.10 $1.10 $0.83 - $3.85 $54.4M 49.5M 59.3K -$0.18

Curasight Financials Summary

As of 30-Jun-2026, Curasight has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 154,588 81,311 24,201 48,312
Revenue 0 0 0 0
EBITDA (9,439) (8,276) (5,737) (4,662)
Net Income (8,581) (8,042) (5,343) (3,798)
Total Assets 8,568 7,872 3,305 5,752
Total Debt 0 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Curasight Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Curasight‘s full profile, request access.

Request a free trial

Curasight Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Curasight‘s full profile, request access.

Request a free trial

Curasight Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Curasight Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Curasight‘s full profile, request access.

Request a free trial

Curasight Acquisitions (1)

Curasight’s most recent deal was a Merger/Acquisition with TRT Innovations for . The deal was made on 10-Feb-2022.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
TRT Innovations 10-Feb-2022 Merger/Acquisition Drug Discovery
To view Curasight’s complete acquisitions history, request access »

Curasight ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Curasight’s complete esg history, request access »

Curasight FAQs

  • When was Curasight founded?

    Curasight was founded in 2013.

  • Where is Curasight headquartered?

    Curasight is headquartered in Copenhagen, Denmark.

  • What is the size of Curasight?

    Curasight has 6 total employees.

  • What industry is Curasight in?

    Curasight’s primary industry is Biotechnology.

  • Is Curasight a private or public company?

    Curasight is a Public company.

  • What is Curasight’s stock symbol?

    The ticker symbol for Curasight is CURAS.

  • What is the current stock price of Curasight?

    As of 20-Nov-2026 the stock price of Curasight is $1.10.

  • What is the current market cap of Curasight?

    The current market capitalization of Curasight is $54.4M.

  • What is Curasight’s annual earnings per share (EPS)?

    Curasight’s EPS for 12 months was -$0.18.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process